These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31858845)

  • 1. POM121 overexpression is related to a poor prognosis in colorectal cancer.
    Wang T; Sun H; Bao Y; En R; Tian Y; Zhao W; Jia L
    Expert Rev Mol Diagn; 2020 Mar; 20(3):345-353. PubMed ID: 31858845
    [No Abstract]   [Full Text] [Related]  

  • 2. POM121 is a novel marker for predicting the prognosis of laryngeal cancer.
    Zhao R; Tang G; Wang T; Zhang L; Wang W; Zhao Q; Zhao K
    Histol Histopathol; 2020 Nov; 35(11):1285-1293. PubMed ID: 33016327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
    Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
    Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
    Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
    Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis.
    Han S; Zong S; Shi Q; Li H; Liu S; Yang W; Li W; Hou F
    EBioMedicine; 2017 Jun; 20():61-69. PubMed ID: 28558958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
    Yuan D; Li K; Zhu K; Yan R; Dang C
    Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Musashi2 as a novel predictive biomarker for liver metastasis and poor prognosis in colorectal cancer.
    Zong Z; Zhou T; Rao L; Jiang Z; Li Y; Hou Z; Yang B; Han F; Chen S
    Cancer Med; 2016 Apr; 5(4):623-30. PubMed ID: 26775684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TYMS serves as a prognostic indicator to predict the lymph node metastasis in Chinese patients with colorectal cancer.
    Lu Y; Zhuo C; Cui B; Liu Z; Zhou P; Lu Y; Wang B
    Clin Biochem; 2013 Oct; 46(15):1478-83. PubMed ID: 23810585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/β-catenin signaling pathway and predicts good prognosis.
    Wu Y; Fang G; Wang X; Wang H; Chen W; Li L; Ye T; Gong L; Ke C; Cai Y
    Cancer Biomark; 2019; 24(1):61-70. PubMed ID: 30347601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of tumor susceptibility gene 101 (TSG101) is associated with more aggressive behavior in colorectal carcinoma.
    Gheytanchi E; Saeednejad Zanjani L; Ghods R; Abolhasani M; Shahin M; Vafaei S; Naseri M; Fattahi F; Madjd Z
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1631-1646. PubMed ID: 33616717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of
    Zhang S; Zheng C; Li D; Bei C; Zhang H; Tian R; Song X; Zhu X; Tan S
    Genet Test Mol Biomarkers; 2020 Dec; 24(12):819-824. PubMed ID: 33296260
    [No Abstract]   [Full Text] [Related]  

  • 14. Overexpression of NDUFA4L2 is associated with poor prognosis in patients with colorectal cancer.
    Lv Y; Nie SL; Zhou JM; Liu F; Hu YB; Jiang JR; Li N; Liu JS
    ANZ J Surg; 2017 Dec; 87(12):E251-E255. PubMed ID: 27226356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine threonine tyrosine kinase 1 is a potential prognostic marker in colorectal cancer.
    Hu L; Chen HY; Cai J; Zhang Y; Qi CY; Gong H; Zhai YX; Fu H; Yang GZ; Gao CF
    BMC Cancer; 2015 Apr; 15():246. PubMed ID: 25884558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
    Wu HK; Liu C; Fan XX; Wang H; Zhou L
    Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of SOX8 predicts poor prognosis in colorectal cancer: A retrospective study.
    Wang Y; Yang W; Liu T; Bai G; Liu M; Wang W
    Medicine (Baltimore); 2019 Jul; 98(27):e16237. PubMed ID: 31277140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
    Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
    Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues].
    Lin MX; Wen ZF; Feng ZY; He D
    Ai Zheng; 2008 Dec; 27(12):1321-6. PubMed ID: 19080002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of integrin-linked kinase (ILK) is associated with tumor progression and an unfavorable prognosis in patients with colorectal cancer.
    Li R; Liu B; Yin H; Sun W; Yin J; Su Q
    J Mol Histol; 2013 Apr; 44(2):183-9. PubMed ID: 23108908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.